These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38349224)

  • 21. Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya.
    Makwaga O; Adhiambo M; Mulama DH; Muoma J; Adungo F; Wanjiku H; Ongaya A; Maitha GM; Mwau M
    Pan Afr Med J; 2020; 37():311. PubMed ID: 33654530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
    El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 drug resistance surveillance among parturient women on anti-retroviral therapy in the Eastern Cape, South Africa: Implications for elimination of mother-to-child transmission.
    Adeniyi OV; Obi CL; Goon DT; Iweriebor B; Ajayi AI; Lambert J; Okoh A
    J Clin Virol; 2019 Aug; 117():89-95. PubMed ID: 31255794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
    Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
    J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
    Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH
    J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelago.
    de Pina-Araujo II; Guimarães ML; Bello G; Vicente AC; Morgado MG
    PLoS One; 2014; 9(4):e96201. PubMed ID: 24763617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania.
    Mziray SR; Kumburu HH; Assey HB; Sonda TB; Mahande MJ; Msuya SE; Kiwelu IE
    PLoS One; 2020; 15(9):e0232649. PubMed ID: 32986709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.
    Barth RE; Aitken SC; Tempelman H; Geelen SP; van Bussel EM; Hoepelman AI; Schuurman R; Wensing AM
    Antivir Ther; 2012; 17(2):377-86. PubMed ID: 22297391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance Profiles in Northern Cyprus: First Data Series.
    Guler E; Arikan A; Sultanoglu N; Suer K; Sanlidag T; Sayan M
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):393-400. PubMed ID: 38366753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.
    Yendewa GA; Sahr F; Lakoh S; Ruiz M; Patiño L; Tabernilla A; Deen GF; Sesay M; Salata RA; Poveda E
    J Antimicrob Chemother; 2019 Jul; 74(7):2024-2029. PubMed ID: 30989237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan.
    Rashid A; Kang L; Yi F; Chu Q; Shah SA; Mahmood SF; Getaneh Y; Wei M; Chang S; Abidi SH; Shao Y
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
    de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
    Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.
    Fall-Malick FZ; Tchiakpé E; Ould Soufiane S; Diop-Ndiaye H; Mouhamedoune Baye A; Ould Horma Babana A; Touré Kane C; Lo B; Mboup S
    J Med Virol; 2014 Mar; 86(3):404-10. PubMed ID: 24318486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
    Pang X; He Q; Tang K; Huang J; Fang N; Xie H; Ma J; Zhu Q; Lan G; Liang S
    J Antimicrob Chemother; 2024 May; 79(5):1142-1152. PubMed ID: 38551451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia.
    Dvali N; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2015 Mar; (240):19-24. PubMed ID: 25879553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients.
    Elmi Abar A; Jlizi A; Darar HY; Kacem MA; Slim A
    Diagn Pathol; 2012 Oct; 7():138. PubMed ID: 23044036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.